A study found HPV testing detected high-grade cervical lesions missed by cytology in a cohort screened with CoSara’s assay.

Scipher Medicine plans early physician access for PrismTcell, a blood test to predict abatacept response in rheumatoid ...

A new Pennsylvania law mandates no-cost coverage of blood-based colorectal cancer screening for 2 million residents, aligning ...

Curiox Biosystems expands its leadership team and forms a Strategic Advisory Board to support growth of its centrifuge-free ...

Twist Bioscience launches Twist MRD Express, offering custom molecular residual disease panels with turnaround times starting ...

Malignant mesothelioma is a rare, life-threatening cancer that develops in the thin tissue lining internal organs, with more ...

Genefluence’s rapid PCR test for UTIs is now in clinical use, enabling one-hour detection of pathogens and resistance genes.

The enterprise digital pathology platform, powered by Tribun Health, integrates pathology, radiology, and cardiology imaging ...

Watchmaker Genomics launched a PCR-free whole genome sequencing workflow integrating library prep and normalization.

Ozelle will present its AI-assisted hematology analyzer at MEDICA 2026, offering CBC, 7-part WBC differentials, and digital ...

FDA clears Sekisui Diagnostics’ rapid combo test for COVID-19 and flu A&B, offering CLIA-waived, 510(k)-cleared pathogen ...

Path Fertility secures $2 million NIH grant to develop and validate a semen-based epigenetic assay for NOA and cancer risk.